Today: October 22, 2016, 11:31 pm

China FMD vaccine market: Output reached 3.6 billion millilitres in 2012
Research Report on China Foot and Mouth Disease (FMD) Vaccine Industry, 2013-2017 - a new market research report on 2014-03-31 04:35:01
Foot-and-mouth disease is prevalent in many countries. Since 1980s, animal husbandry has been developing rapidly in China. Because the breeding methods of Chinese farmers are rather laggard, the prevention and control system of animal epidemic diseases is not complete and FMD is popular in the neighboring countries, FMD is always a huge threat to China animal husbandry.

FMD mainly has seven serotypes including Type A, Type O, Type C, Type Asia I, Type South Africa I, Type South Africa II, Type South Africa III, etc. Cloven-hoofed animals like cattle, sheep, pigs, camels and so on are easy to be infected by FMD. In 2004, Type Asia I FMD was transmitted into China. As a result, FMD occurred in China in 2004-2008 all belongs to this type. Because it has rapid spreading speed and high infection rate and it is a serious danger to animal husbandry, FMD is defined as A-level infectious disease by OIE. In addition, China treats it as the first-grade animal epidemic disease and focuses on preventing it.

From 2010 to 2012, the epidemic prevalence of FMD decreased obviously in China as the incidence number greatly declined and the incidence frequency decreased obviously, so the overall epidemic situation was controlled on a quite low level. In terms of Type Asia I FMD, it occurred for 17 times, 8 times, 3 times and 8 times in 2006, 2007, 2008 and 2009 respectively. In 2010, Type O FMD occurred for 18 times in China. By the end of 2012, Type Asia I FMD disappeared for 42 months successively and Type A FMD disappeared for 33 months successively. In 2012, Type O FMD only occurred for 5 times in China.

According to the Animal Epidemic Prevention Law of the People´s Republic of China issued by Chinese government in July 1997, Chinese government adopts compulsory immunization measures for FMD. Specifically, Chinese government purchases FMD vaccines from animal vaccine manufacturers and freely distributes them to the farmers in the animal husbandry. In 2012, China´s total output volume of FMD Vaccines was about 3.6 billion milliliters (2.1 billion milliliters of pig FMD vaccines, 1.5 billion milliliters of cattle & sheep FMD vaccines), with the total output volume of CAHIC, Inner Mongolia Jinyu Group Stock Company and Xinjiang Tecon Animal Husbandry Bio-Technology Co., Ltd. accounting for 80%. Because there are a few FMD vaccine manufacturers in China with high market concentration rate, government´s purchasing price is comparatively stable in recent years.

In China, FMD vaccines belong to national compulsory vaccines, which are purchased by Chinese government and freely distributed to farmers. Theoretically, commercial FMD vaccines do not exist. However, in the process of free distribution, there is a phenomenon that some people charge farmers for FMD vaccines. Meanwhile, because some problems may occur in the process of manufacturing, conserving and transporting FMD vaccines, many free vaccines will lose immune efficacy. Some Chinese breeding enterprises, especially enterprises that breed pigs, start purchasing imported FMD vaccines that are smuggled from other countries or commercial FMD vaccines that are produced by domestic enterprises. Although the above behaviors are suspected of breaking laws, it cannot be denied that China commercial FMD vaccine market still possesses extremely huge space.

One of the characteristics of China animal vaccine industry is that it is promoted by typical events. When serious epidemic situation occurs in China or other countries, Chinese government will purchase more vaccines. Therefore, the bad news (outbreak of epidemic diseases) to animal husbandry is just the development opportunities (increase in purchasing varieties and volume) for animal vaccine industry.

Click for report details: ..

Browse all Healthcare and Medical Market Research Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Market Research Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Press Information

Published by
Mike King
London: +44 (0) 203 086 8600

# 782 Words
Related Articles
More From Finance
P2P lending platform Monexo partners with IDBI-Trusteeship [..]
For Immediate Release: 2nd September 2016 MUKESH BUBNA, CEO Monexo Fintech Pvt Limited P2P [..]
Day Trade to Win New September Class [..]
Sold Out? New Class Added – On September 6, 2016, is launching a brand new eight-week trading boot camp [..]
FTM (Forget The Market) Reopens 3 Shares [..]
Port Vila, Vanuatu, 28th July 2016 - Investment firm FTM today announced the reopening of three separate share options, projected [..]
Ex-Citibanker Launching Online P2P marketplace in India [..]
A study conducted by World Bank shows that MSMEs in India face an estimated credit gap of INR 20.9 trillion [..]
New Frontier Portfolios Top Morningstar Rankings
New Frontier’s global strategic portfolios topped the Global Balanced Strategic/All-Inclusive category of the latest Morningstar ETF [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.